Long Term Intrathecal Baclofen Therapy in Patients with Intractable Spasticity

Abstract Background Severe spasticity unresponsive to oral drugs may respond satisfactorily to baclofen delivered intrathecally. Methods Intrathecal baclofen (IB) therapy delivered by means of implanted infusion pumps was used for nine patients with severe spasticity. Six patients had multiple sclerosis, two cervical spinal cord injury, and one head injury. All were non-ambulatory. Results Patients showed improvement in many areas, including ability to transfer, seating, pain control, personal care, and liability to skin breakdown. Before IB therapy, only three of the nine patients were able to live at home in the community and six were institutionalized. At the end of our follow-up period, only one patient remained institutionalized, three lived in group homes and five lived at home in the community. In the year preceding pump implantation, the nine patients spent a total of 755 days in acute care hospitals. In the year following onset of IB therapy, they spent only 259 days in hospital. Conclusions IB therapy can improve patient quality of life and can be cost-effective in carefully selected patients with severe spasticity and disability. The drug delivery catheter is that part of the therapeutic system most vulnerable to failure. Because of the varied expertise required to manage these patients effectively, and the potential for a variety of complications, it is essential that an IB program is supported by a well-organized multi-disciplinary medical team.

[1]  R. Penn,et al.  Intrathecal baclofen down-regulates GABAB receptors in the rat substantia gelatinosa. , 1993, Journal of neurosurgery.

[2]  R. Penn,et al.  The distribution of medication along the spinal canal after chronic intrathecal administration. , 1993, Neurosurgery.

[3]  B. Bussel,et al.  Effect of intrathecal baclofen on the monosynaptic reflex in humans: evidence for a postsynaptic action. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[4]  R. Penn,et al.  Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. , 1993, Journal of neurosurgery.

[5]  S. Tuel,et al.  CONTINUOUS INTRATHECAL BACLOFEN IN SPINAL CORD SPASTICITY: A Prospective Study , 1992, American journal of physical medicine & rehabilitation.

[6]  C. Chabal,et al.  Development of an acute withdrawal syndrome following the cessation of intrathecal baclofen in a patient with spasticity. , 1992, Anesthesiology.

[7]  R. Penn Intrathecal baclofen for spasticity of spinal origin: seven years of experience. , 1992, Journal of neurosurgery.

[8]  S. Shapiro,et al.  Efficacy of dorsal longitudinal myelotomy in treating spinal spasticity: a review of 20 cases. , 1991, Journal of neurosurgery.

[9]  A. L. Albright,et al.  Intrathecal baclofen for spasticity in cerebral palsy. , 1991, JAMA.

[10]  M. Sánchez-Ledesma,et al.  Chronic intrathecal baclofen administration in severe spasticity. , 1990, Stereotactic and functional neurosurgery.

[11]  C. Behrens,et al.  Kontinuierliche intrathecale Baclofen-Therapie mittels implantierbarer Pumpensysteme bei schwerer Spastik , 1990 .

[12]  M. Latash,et al.  Effects of intrathecal baclofen on voluntary motor control in spastic paresis. , 1990, Journal of neurosurgery.

[13]  Y. Lazorthes,et al.  Chronic intrathecal baclofen administration for control of severe spasticity. , 1990, Journal of neurosurgery.

[14]  F. Edwards,et al.  Reduction by baclofen of monosynaptic EPSPs in lumbosacral motoneurones of the anaesthetized cat. , 1989, The Journal of physiology.

[15]  J. Gybels,et al.  Intrathecal baclofen for long-term treatment of spasticity: a multi-centre study. , 1989, Journal of neurology, neurosurgery, and psychiatry.

[16]  R. Penn,et al.  Effect of intrathecal baclofen on bladder and sphincter function. , 1989, The Journal of urology.

[17]  M. Latash,et al.  Intrathecal Baclofen for Severe Spinal Spasticity , 1989, The New England journal of medicine.

[18]  R. Penn,et al.  Intrathecal Baclofen Infusion: Effect on Bladder Management Programs in Patients with Myelopathy , 1989, American journal of physical medicine & rehabilitation.

[19]  E. Frank,et al.  Activation of GABAB receptors causes presynaptic inhibition at synapses between muscle spindle afferents and motoneurons in the spinal cord of bullfrogs , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  R. Penn,et al.  Long-term intrathecal baclofen infusion for treatment of spasticity. , 1987, Journal of neurosurgery.

[21]  R. Penn,et al.  CONTINUOUS INTRATHECAL BACLOFEN FOR SEVERE SPASTICITY , 1985, The Lancet.

[22]  J. B. Blacklock,et al.  Control of spasticity by implantable continuous flow morphine pump. , 1985, Neurosurgery.

[23]  R. Beauchamp,et al.  Selective functional posterior rhizotomy for treatment of spastic cerebral palsy in children. Review of 50 consecutive cases. , 1992, Pediatric neurosurgery.

[24]  W. Donovan,et al.  Continuous infusion of intrathecal baclofen: long-term effects on spasticity in spinal cord injury , 1991, Paraplegia.

[25]  W. Braunsdorf,et al.  [Continuous intrathecal baclofen therapy using an implantable pump system in severe spasticity]. , 1990, Neurochirurgia.

[26]  T. Wurdinger,et al.  Implanted pump systems for treatment of spasticity. , 1988, Acta neurochirurgica. Supplementum.